Outcomes with non-small cell lung cancer and brain-only metastasis
In patients with NSCLCwt with BOM, we observed a -predominant pattern of brain-only secondary progression, however patients with NSCLCmut + more often progressed extracranially. In patients with NSCLCmut+ and BOM, definitive primary tumor treatment correlated with improved survival.
Authors
- Miguel García-Pardo (ORCID: https://orcid.org/0000-0001-6339-8501)
- M. Chowdhury (ORCID: https://orcid.org/0000-0002-8142-1901)
- Khaleeq Khan
- Evan Strom (ORCID: https://orcid.org/0000-0002-4452-6042)
- M. Catherine Brown (ORCID: https://orcid.org/0000-0003-0184-7732)
- Adrian G. Sacher (ORCID: https://orcid.org/0000-0001-7865-2701)
- David Shultz (ORCID: https://orcid.org/0000-0001-8242-6555)
- Joshua Herman (ORCID: https://orcid.org/0000-0002-7411-1147)
- Amir Sabouhanian (ORCID: https://orcid.org/0000-0002-5573-5157)
- Luna Jia Zhan (ORCID: https://orcid.org/0000-0003-2534-7230)
- Frances A. Shepherd (ORCID: https://orcid.org/0000-0002-3610-3533)
- Sabine Schmid (ORCID: https://orcid.org/0000-0003-0840-3253)
- Geoffrey Liu (ORCID: https://orcid.org/0000-0002-2603-7296)
- Wei Xu (ORCID: https://orcid.org/0000-0002-0257-8856)
- Sierra Cheng (ORCID: https://orcid.org/0000-0002-4594-5337)
- Natasha B. Leighl
- Preet Walia
- Devalben Patel
- Penelope A. Bradbury
Institutions
- University of Bern (CH)
- University Health Network (CA)
- Instituto Cajal (ES)
- University Hospital of Bern (CH)
- Princess Margaret Cancer Centre (CA)
Publication Details
- Journal
- Heliyon
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e37082
- Citations
- 2
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- Swiss Cancer Research Foundation